ImmuPharma plcLSE: IMM

AGM Result

· Issued by ImmuPharma plc
RNS Number : 7058A
Immupharma PLC
05 August 2008
 

For Immediate Release

5 August 2008

AGM Statement 

ImmuPharma plc (LSE:IMM), the specialist pharmaceutical discovery and development company, held its AGM earlier today and is pleased to announce that all resolutions were passed.

 

For further information please contact: 

ImmuPharma PLC 

Dimitri Dimitriou, Chief Executive Officer                            +44 20 7152 4080
Richard Warr, Chairman                                                  +44 20 7152 4080

Dr Robert Zimmer, President & Chief                                 +33 389 32 76 50

Scientific Officer 

Buchanan Communications                                         +44 20 7466 5000

Lisa Baderoon
Rebecca Skye 
Dietrich 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RAGILFSSTLIEIIT

ImmuPharma plc on 6ix

Earlier from ImmuPharma

Later from ImmuPharma

All ImmuPharma news releases